Alpha Teknova (TKNO) Capital Expenditures (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Capital Expenditures came in at $221000.0 in Q1 2026, up 7.28% year-on-year from $206000.0 in Q1 2025, and down 36.49% on a QoQ basis from $348000.0 in Q4 2025.
Alpha Teknova (TKNO) Capital Expenditures (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Capital Expenditures data on file, last reported at $221000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures rose 7.28% year-over-year to $221000.0 in Q1 2026; TTM through Mar 2026 was $1.2 million, a 4.59% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, up 2.04% from the prior year.
- Capital Expenditures for Q1 2026 stood at $221000.0, down from $348000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for TKNO reached as high as $10.9 million in Q2 2022 and fell as low as $112000.0 in Q1 2024.
- Historically, Capital Expenditures has averaged $2.3 million across 5 years, with a median of $387000.0 in 2025.
- Across the five-year window, Capital Expenditures jumped 133.63% in 2022 and sank 97.4% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $4.7 million in 2022, then slumped by 93.4% to $312000.0 in 2023, then soared by 81.73% to $567000.0 in 2024, then slumped by 38.62% to $348000.0 in 2025, then sank by 36.49% to $221000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $221000.0 in Q1 2026, $348000.0 in Q4 2025, and $387000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 221,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221,000.00 |
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Sep 30, 2025 | 387,000.00 |
| Sep 30, 2025 | 387,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Mar 31, 2025 | 206,000.00 |
| Mar 31, 2025 | 206,000.00 |
| Dec 31, 2024 | 567,000.00 |
| Dec 31, 2024 | 567,000.00 |
| Sep 30, 2024 | 331,000.00 |
| Sep 30, 2024 | 331,000.00 |
| Jun 30, 2024 | 115,000.00 |
| Jun 30, 2024 | 115,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | 312,000.00 |
| Dec 31, 2023 | 312,000.00 |